Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jersey City, New Jersey
- Most recent report
- 8-K, filed Oct 30, 2026
- Incorporated
- N/A
- Filings on record
- 461 filings
- On EDGAR
- CIK 1821825
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 26
News 8 of 49
- 8-K Current report on a material event Oct 30, 2026
- 8-K Current report on a material event Jul 31, 2026
- 8-K Shareholder vote results Jul 23, 2026
- 8-K Other events Jul 17, 2026
- 8-K Leadership change Jun 11, 2026
- 8-K Quarterly results Apr 30, 2026
- 8-K Leadership change Apr 27, 2026
- 8-K Other events Feb 20, 2026
Prospectuses and Registrations 2
Proxies 8 of 20
Ownership 8 of 338
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 31, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
Other 8 of 26
- SD Conflict minerals disclosure May 29, 2026
- ARS Annual report sent to shareholders Apr 24, 2026
- SD Conflict minerals disclosure Jun 2, 2025
- ARS Annual report sent to shareholders Apr 25, 2025
- UPLOAD Comment letter from SEC staff Jun 25, 2024
- CORRESP Reply to SEC staff Jun 6, 2024
- SD Conflict minerals disclosure May 28, 2024
- UPLOAD Comment letter from SEC staff May 23, 2024
Everything here comes from Organon & Co.'s own filings on SEC EDGAR. The filing list is rechecked every hour.